Tenecteplase Is a Better Alternative to Alteplase for Patients With Large Vessel Occlusion Stroke Receiving Bridging Therapy
- PMID: 38865680
- DOI: 10.1212/WNL.0000000000209581
Tenecteplase Is a Better Alternative to Alteplase for Patients With Large Vessel Occlusion Stroke Receiving Bridging Therapy
Comment on
-
Functional Outcome and Hemorrhage Rates After Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core.Neurology. 2024 Jul 9;103(1):e209398. doi: 10.1212/WNL.0000000000209398. Epub 2024 Jun 11. Neurology. 2024. PMID: 38862134
Similar articles
-
Functional Outcome and Hemorrhage Rates After Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core.Neurology. 2024 Jul 9;103(1):e209398. doi: 10.1212/WNL.0000000000209398. Epub 2024 Jun 11. Neurology. 2024. PMID: 38862134
-
Intravenous thrombolysis with tenecteplase versus alteplase in acute ischemic stroke tandem occlusions: a systematic review and meta-analysis of current available literature.J Thromb Thrombolysis. 2025 Mar;58(3):411-419. doi: 10.1007/s11239-025-03084-4. Epub 2025 Mar 13. J Thromb Thrombolysis. 2025. PMID: 40082388
-
Early Recanalization Among Patients Undergoing Bridging Therapy With Tenecteplase or Alteplase.Stroke. 2023 Oct;54(10):2491-2499. doi: 10.1161/STROKEAHA.123.042691. Epub 2023 Aug 25. Stroke. 2023. PMID: 37622385
-
Short-Term Safety and Effectiveness for Tenecteplase and Alteplase in Acute Ischemic Stroke.JAMA Netw Open. 2025 Mar 3;8(3):e250548. doi: 10.1001/jamanetworkopen.2025.0548. JAMA Netw Open. 2025. PMID: 40072434 Free PMC article.
-
Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.J Am Heart Assoc. 2024 May 7;13(9):e031692. doi: 10.1161/JAHA.123.031692. Epub 2024 Apr 30. J Am Heart Assoc. 2024. PMID: 38686848 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources